Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1299-1304

  Murata, Yoriko ^a   Ogawa, Yasuhiro ^a   Saibara, Toshiji ^a   Nishioka, Akihito ^a   Fujiwara, Yoshimasa ^a   Fukumoto, Mitsutaka ^a   Inomata, Taisuke ^a   Enzan, Hideaki ^a   Onishi, Saburo ^a   Yoshida, Shoji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Computed tomography; Estrogen; Fatty liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ASPARTATE AMINOTRANSFERASE; CAF PROTOCOL 2; CHOLESTEROL; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG DERIVATIVE; FLUOROURACIL; TAMOXIFEN; TRIACYLGLYCEROL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; FATTY LIVER; FEMALE; HUMAN; MALE; MIDDLE AGED; TOXIC HEPATITIS;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHOLESTEROL; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FATTY LIVER; FEMALE; FLUOROURACIL; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; TAMOXIFEN; TRIGLYCERIDES;

EID: 0034322415     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.6.1299     Document Type: Article

References (27)

1. Wilcken NR: Tamoxifen hits the target in situ. Lancet 353: 1986-1987, 1999.
2. Fischer B, Constantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin W, et al. Tamoxifen for early breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 90: 1371-1388, 1998.
3. Fischer B, Dignam J, Wolmark N, Wickerham DL, Fischer E, Mamounas E, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 353: 1993-2000, 1999.
4. Katase K, Sugimura Y, Hasumi K, Yoshimoto M and Kasumi F: The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Cancer 82: 1698-1703, 1998.
5. Ludwig J, Viggiano TR, McGill DB and Ott B: Non-alcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438, 1980.
6. James O and Day C: Non-alcoholic steatohepatitis: another disease of affluence. Lancet 353: 1634-1636, 1998.
7. Ogawa Y, Murata Y, Nishioka A, Inomata T and Yoshida S: Tamoxifen-induced fatty liver, in patients with breast cancer. Lancet 351:725, 1998.
8. Saibara T, Onishi S, Ogawa Y, Yoshida S and Enzan H: Bezafibrate for tamoxifen-induced fatty liver in breast cancer patients. Lancet 353: 1802, 1999.
9. Oien KA, Moffat D, Curry GW, Dickson J, Habeshaw T, Mills PR, et al. Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 353: 36-37, 1999.
10. Ogawa Y, Nishioka A, Inomata T, Tsuboi N, Hayase N, Fukumoto M, et al: Conservation treatment intensified with tamoxifen and CAP chemotherapy for subarcolar breast cancers. Oncol Rep 5: 1337-1341, 1998.
11. Ogawa Y, Nishioka A, Inomata T, Yokota N, Sasaki T, Terashima M, et al. Conservation treatment intensified with tamoxifen and CAP chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes. Oncol Rep 6: 801-805, 1999.
12. Ogawa Y, Nishioka A, Inomata T, Ohnishi T, Kariya S, Terashima M, et al. Conservation treatment intensified with an anti-estrogen agent and CAP chemotherapy for stage I and II breast cancer. Oncol Rep 7: 479-484, 2000.
13. The Japanese Breast Cancer Society: Results of questionnaires concerning breast cancer surgery in Japan: an update in 1998. Breast Cancer 5: 211, 1998.
14. Nishioka A, Ogawa Y, Hamada N, Terashima M, Inomata T and Yoshida S: Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast conservation treatment. Oncol Rep 6: 513-517, 1999.
15. Tsuboi N, Ogawa Y, Inomata T, Yoshida D, Yoshida S, Moriki T, et al. Changes in the findings of dynamic MRI by preoperative CAP chemotherapy for detection of axillary lymph node metastases in breast cancer. Oncol Rep 5: 1403-1406, 1998.
16. Ricci C, Longo R, Gioulis E, Bosco M, Pollesselo P, Masutti F, et al: Non-invasive in vitro quantitative assessment of fat content in human liver. J Hepatol 27: 108-113, 1997.
17. Nomura F, Ohnishi K, Ochiai T and Okuda K: Obesity-related non-alcoholic fatty liver: CT features and follow-up studies after low-calorie diet. Radiology 162: 845-847, 1987.
18. Kato K, Takayama T, Katada N, Nishimura T, Shibata T, Kato A, et al: Evaluation of computed tomography in the diagnosis of liver diseases. Acta Hepatol Jpn 21: 1340-1351, 1980.
19. Pinto HC, Baptista A, Camilo ME, Costa ME, Costa EB, Valente A and Moura MC: Tamoxifen-associated steatohepatitis-report of three cases. J Hepatol 23: 95-97, 1995.
20. Hoof M, Rahieer J and Hansmans Y: Tamoxifen-induced steatohepatitis. Ann Intern Med 124: 855-856, 1996.
21. Saibara T, Ogawa Y and Onishi S: Tamoxifen in early breast cancer. Lancet 352: 404, 1998.
22. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA and Evans RM: PPARgamma promotes monocytes/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252, 1998.
23. Nagy L, Tontonoz P, Alvarez JG, Chen H and Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240, 1998.
24. Nemoto Y, Toda K, Ono M, Adachi K, Saibara T, Onishi S, et al: Altered constitutive expression of fatty acid-metabolizing enzymes in aromatase-deficient (ArKO) mice. J Clin Invest (In press).
25. Day CP and James OFW: Steatohepatitis: a tale of two 'hits'? Gastroenterology 114: 842-845, 1998.
26. Day CP and James OF: Hepatic steatosis: innocent bystander or guilty party? Hepatology 27: 1463-1466, 1996.
27. Saibara T, Onishi S, Ogawa Y, Yoshida S and Enzan H: Nonalcoholic steatohepatitis. Lancet 354: 1229-1300, 1999.